Viewing Study NCT04500067


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT04500067
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2020-07-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
Sponsor: Biopharma Plasma LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module